[Further details on identity and specification of active substance are provided in the review report.]
Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions
Halauxifen-methyl
CAS No: 943831-98-9
CIPAC No: 970.201 (halauxifen-methyl) 970 (halauxifen)
methyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylate | ≥ 930 g/kg | 5 August 2015 | 5 August 2025 |
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on halauxifen-methyl, and in particular Appendices I and II thereof, shall be taken into account.
In this overall assessment Member States shall pay particular attention to:
The risk to aquatic and non-target terrestrial plants.
Conditions of use shall include risk mitigation measures, where appropriate.
The applicant shall submit confirmatory information as regards:
The technical specification of the active substance as manufactured (based on commercial scale production). The relevance of impurities present in the technical material should be confirmed,
The compliance of the toxicity batches with the technical specification.
The applicant shall submit that information to the Commission, the Member States and the Authority by 5 February 2016.